Iridex (IRIX) Current Deferred Revenue (2016 - 2026)
Iridex has reported Current Deferred Revenue over the past 16 years, most recently at $2.2 million for Q1 2026.
- Quarterly results put Current Deferred Revenue at $2.2 million for Q1 2026, down 0.74% from a year ago — trailing twelve months through Jan 2026 was $2.2 million (down 0.74% YoY), and the annual figure for FY2026 was $2.2 million, down 0.74%.
- Current Deferred Revenue for Q1 2026 was $2.2 million at Iridex, down from $2.2 million in the prior quarter.
- Over the last five years, Current Deferred Revenue for IRIX hit a ceiling of $14.9 million in Q3 2022 and a floor of $2.1 million in Q1 2025.
- Median Current Deferred Revenue over the past 5 years was $2.3 million (2024), compared with a mean of $5.7 million.
- Biggest five-year swings in Current Deferred Revenue: surged 982.72% in 2022 and later plummeted 84.5% in 2023.
- Iridex's Current Deferred Revenue stood at $14.2 million in 2022, then fell by 12.18% to $12.4 million in 2023, then plummeted by 82.49% to $2.2 million in 2024, then grew by 1.47% to $2.2 million in 2025, then dropped by 2.17% to $2.2 million in 2026.
- The last three reported values for Current Deferred Revenue were $2.2 million (Q1 2026), $2.2 million (Q3 2025), and $2.3 million (Q2 2025) per Business Quant data.